Patient question · asked by Anonymous reader · September 22, 2026
Why does a low dose of cannabis help my anxiety?
Why does a low dose of cannabis help my anxiety and pain, but if I take slightly more it suddenly makes my anxiety worse and my heart race? Why does it flip like that?
Patient question: Why does a low dose of cannabis help my anxiety and pain, but if I take slightly more it suddenly makes my anxiety worse and my heart race? Why does it flip like that? Cannabis compounds often produce what pharmacologists call a "biphasic effect," meaning low doses and higher doses can produce opposite.
The short answer
Dr. Caplan & CED Research Response
Cannabis compounds often produce what pharmacologists call a "biphasic effect," meaning low doses and higher doses can produce opposite reactions in the body. While a small amount of THC can calm the nervous system and relieve pain, exceeding your personal threshold can overstimulate the same cannabinoid receptors, triggering acute anxiety, a racing heart, and heightened sensitivity.
A closer lookWhy the answer is what it is
The phenomenon of feeling relief at one dose and distress at a higher dose is one of the most common surprises for patients, but it is well-documented in clinical pharmacology. Cannabinoids like THC act primarily on CB1 receptors throughout the central nervous system. At lower concentrations, THC gently modulates neurotransmitter release, dampening the "fight-or-flight" response and dialing down pain perception.
When the dose increases past an individual's therapeutic window, THC shifts from calming the system to overactivating sympathetic nervous activity. This receptor saturation can provoke rapid heart rate (tachycardia), transient paranoia, and paradoxically increase pain sensitivity (hyperalgesia). A scoping review examining dose responses across dozens of clinical publications confirmed that pain, anxiety, and sleep all display this characteristic U-shaped or inverted U-shaped response curve.
Because every person's endocannabinoid receptor density, metabolism, and tolerance are unique, this turning point varies widely from one individual to the next. In clinical practice, finding your optimal dose is never about taking "more"; it is about finding the minimum effective amount that delivers relief without tipping over into the second phase of the curve.
The evidence
The study behind this answer
Verified on PubMed Systematic review or meta-analysis
Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review
PubMed 38268491
Read the abstract as published
INTRODUCTION: Cannabinoids are being used by patients to help with chronic pain management and to address the 2 primary chronic pain comorbidities of anxiety and sleep disturbance. It is necessary to understand the biphasic effects of cannabinoids to improve treatment of this symptom triad. METHODS: A scoping review was conducted to identify whether biphasic effects of cannabinoids on pain severity, anxiolysis, and sleep disturbance have been reported. The search included the Embase, Biosis, and Medline databases of clinical literature published between 1970 and 2021. The inclusion criteria were (1) adults more than 18 years of age, (2) data or discussion of dose effects associated with U-shaped or linear dose responses, and (3) measurements of pain and/or anxiety and/or sleep disturbance. Data were extracted by 2 independent reviewers (with a third reviewer used as a tiebreaker) and subjected to a thematic analysis. RESULTS: After the database search and study eligibility assessment, 44 publications met the final criteria for review. Eighteen publications that specifically provided information on dose response were included in the final synthesis: 9 related to pain outcomes, 7 measuring anxiety, and 2 reporting sleep effects. CONCLUSIONS: This scoping review reports on biphasic effects of cannabinoids related to pain, sleep, and anxiety. Dose-response relationships are present, but we found gaps in the current literature with regard to biphasic effects of cannabinoids in humans. There is a lack of prospective research in humans exploring this specific relationship.
Abstract text as indexed by PubMed for this identifier.
Limitations the authors noted
Heterogeneity of study populations, methods, exposures, and effect measurements. Small sample sizes across most included primary studies except one. Exclusion of non-English studies and articles not indexed with specific search terms.
More on Anxiety More on Chronic pain More on Sleep wake disorders
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on September 22, 2026.
This answer is general education. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation. In an emergency, call 911.